Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation (VENOCAT) Pilot Study

NCT06887270 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT06887270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06887270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation (VENOCAT) Pilot Study
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
September 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, cancer, central venous catheter, direct oral anticoagulant, periprocedural complication